In an animal model, these immune exclusion properties were also recapitulated, and a TGF-β-blocking antibody together with anti-PD-L1 reduced TGF-β signaling in stromal cells, facilitated T cell entry into the center of the tumor, and elicited potent anti-tumor immunity [42]. Here, TGFB1 is linked to neoplasm.